FDA Approves RSV Vaccine for Pregnant Individuals to Prevent Virus in Infants
The respiratory syncytial virus (RSV) vaccine Abrysvo is approved for use in pregnant individuals to prevent the RSV in infants up to 6 months of age.
Source: ajmc.com
Group Bivalent News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Group Bivalent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Group Bivalent Today - Breaking & Trending Today